PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2009 by Foundation for Cardiovascular Research, Zurich.
Recruitment status was Active, not recruiting

Sponsor:

Collaborator:

AGA Medical Corporation

Information provided by:

Foundation for Cardiovascular Research, Zurich

ClinicalTrials.gov Identifier:

NCT00166257

First received: September 9, 2005

Last updated: May 26, 2009

Last verified: May 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	May 2011
Estimated Primary Completion Date:	February 2011 (Final data collection date for primary outcome measure)

No publications provided by Foundation for Cardiovascular Research, Zurich

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716.

Khattab AA, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design. Trials. 2011 Feb 28;12:56.

To Top